On this page
What this guide covers
Wegovy (semaglutide) is the same active ingredient as Ozempic but is dosed higher for weight management, so nausea, diarrhea, and constipation are common, especially during dose increases. Here is what the FDA label and the STEP trials report, plus the serious warnings and the symptoms that mean you should call your doctor. This is patient education, not a substitute for the prescriber who knows your case. Generic names sit next to brand names throughout: semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound).
Key points
- The common side effects are mostly digestive. The great majority of Wegovy side effects are gastrointestinal. In the STEP weight-management trials of semaglutide 2.4 mg, the most frequently reported reactions were nausea, diarrhea, vomiting, and constipation, along with abdominal pain, indigestion, and burping. Most of these were mild to moderate and eased as people stayed on a given dose. They tend to be heaviest in the first weeks and right after each dose increase, then settle as the body adjusts. This pattern is worth expecting rather than fearing: it means a rough few days after a step up is usually temporary, not a sign that something is wrong. If a symptom is severe, is not easing, or is stopping you eating and drinking, that is the point to loop in your prescriber rather than pushing through alone.
- The slow dose climb exists to limit them. Wegovy does not start at its full dose, and that is deliberate. The FDA label steps the dose up gradually over about 16 to 20 weeks, from a starter dose that is not meant to do much, through several increases, to the 2.4 mg maintenance dose used in the STEP trials. The whole point of that slow ladder is to give your gut time to adapt and to keep the nausea and other digestive effects manageable, because they cluster around each increase. The label also allows delaying a step up if a dose is not yet tolerated, so if an increase hits hard, staying longer at your current dose is a normal, expected adjustment rather than a failure. That decision belongs with your prescriber, but knowing it is an option takes some of the pressure off.
- The serious warnings on the label. Beyond the common digestive effects, the Wegovy label carries warnings that are rarer but matter. It has a boxed warning about thyroid C-cell tumors seen in rodent studies, and it should not be used by people with a personal or family history of medullary thyroid carcinoma or the syndrome MEN 2. The label also warns about pancreatitis (inflammation of the pancreas), gallbladder problems and gallstones, acute kidney injury that can follow dehydration from vomiting or diarrhea, and, for people also taking insulin or a sulfonylurea, a higher risk of low blood sugar. Serious allergic reactions can occur too. These are not reasons to panic, most people never experience them, but they are the reasons the drug is prescription-only and monitored, and the reasons certain symptoms below should never be ignored.
- Same molecule as Ozempic, dosed higher. Wegovy and Ozempic are both semaglutide, so their side-effect profiles are close cousins, but Wegovy is titrated to a higher maintenance dose (2.4 mg) for weight management, which is part of why digestive effects can feel more pronounced. Beyond the gut, some people notice fatigue, and hair thinning is reported, most often the temporary shedding that can follow any rapid weight loss rather than a direct drug effect on the follicle. Injection-site reactions and, rarely, allergic reactions can happen as with any injectable. If you have read about Ozempic side effects, the broad picture carries over, the main practical difference is that the higher weight-management dose can make the early adjustment period more noticeable, which is exactly why the gradual dose schedule matters.
- Managing the common effects, and the red flags. For everyday digestive side effects, the basics genuinely help: smaller and more frequent meals, easing off very fatty or very large plates, sipping fluids steadily to stay ahead of dehydration, and giving each new dose a week or two before judging it. Constipation responds to fluids, movement, and the right kind of fiber; diarrhea and vomiting make hydration the priority. The symptoms that should prompt a prompt call, not a wait, are severe or persistent abdominal pain, especially pain that bores through to your back or comes with vomiting (a possible sign of pancreatitis or a gallbladder problem), signs of dehydration such as dizziness or barely passing urine, and any signs of an allergic reaction like hives, swelling, or trouble breathing. When something feels out of proportion to the usual queasy adjustment, that instinct is worth trusting.
Frequently asked questions
What are the most common side effects of Wegovy?
In the STEP trials of semaglutide 2.4 mg, the most common Wegovy side effects were gastrointestinal: nausea, diarrhea, vomiting, and constipation, along with abdominal pain, indigestion, and burping. Most were mild to moderate and eased as people stayed on a given dose. They are typically heaviest in the first weeks and just after each dose increase, then settle as the body adjusts.
How long do Wegovy side effects last?
For most people the common digestive side effects are worst in the first weeks and after each dose step, then improve as the body adapts to that dose. The gradual dose schedule over about 16 to 20 weeks is designed to keep them manageable. If a symptom is severe, is not easing over a week or two, or is stopping you eating and drinking, contact your prescriber rather than pushing through, since the dose climb can be slowed.
What are the serious side effects of Wegovy?
The Wegovy label carries a boxed warning about thyroid C-cell tumors (it should not be used by people with a personal or family history of medullary thyroid carcinoma or MEN 2), and it warns about pancreatitis, gallbladder disease and gallstones, acute kidney injury from dehydration, low blood sugar when combined with insulin or a sulfonylurea, and serious allergic reactions. These are uncommon, but they are why symptoms like severe abdominal pain or signs of dehydration should be reported promptly.
Does Wegovy have worse side effects than Ozempic?
Wegovy and Ozempic are the same active ingredient, semaglutide, so their side-effect profiles are very similar. The main difference is that Wegovy is titrated to a higher maintenance dose (2.4 mg) for weight management, which can make the digestive effects feel more pronounced, particularly during the dose-increase weeks. That is exactly why Wegovy uses a gradual dose schedule and why slowing the climb is an accepted option if an increase is hard to tolerate.
When should I call my doctor about Wegovy side effects?
Call promptly for severe or persistent abdominal pain (especially pain that radiates to your back or comes with vomiting), signs of dehydration such as dizziness or passing very little urine, or symptoms of low blood sugar if you also take insulin or a sulfonylurea. Treat it as an emergency, and do not take another dose, if you have signs of an allergic reaction such as hives, swelling of the face or throat, or trouble breathing. When a symptom feels out of proportion to the usual queasy adjustment, trust that and check in.
Sources
Related reading
Ozempic Constipation: Best Fiber Picks
Yes, Ozempic and other GLP-1s commonly cause constipation, here's why it happens, how long it usually lasts, and what actually relieves it, including which fiber to buy and which to skip.
Ozempic Week by Week: What to Expect
A week-by-week timeline of the first year on semaglutide. What is normal. What is not. When to call your doctor.
The Complete GLP-1 Side Effect Guide: Week by Week
Every common GLP-1 side effect, the week it typically appears, why it happens, and what actually helps. With citations from trial data and manufacturer labels.
